Don’t forget you can visit MyAlerts to manage your alerts at any time.
By Max Mitchell | April 19, 2017
The first lawsuit filed in Pennsylvania over the shingles vaccine has been dismissed with a federal judge saying the suit was begun after the statute of limitations had run out.
1 minute read
By P.J. D'Annunzio | April 17, 2017
The Philadelphia judge did not explain his decision, but another lawsuit was tossed in December shortly after the defense started their case.
1 minute read
By Jenna Greene | April 16, 2017
Any litigator knows a case can rise or fall on the testimony of an expert witness. A New Jersey state judge made that abundantly clear when he skewered the plaintiffs' two experts in a long-running fight over the acne drug Accutane, banning their testimony and handing a huge win to Hoffman La Roche and Covington & Burling.
1 minute read
By P.J. D'Annunzio | April 14, 2017
After two attempts to get out of a whistleblower case, Pfizer is still on the hook for claims that it illegally marketed an anti-fungal medication, Vfend, for off-label use.
1 minute read
By Charles Toutant | April 13, 2017
Roxane Laboratories must pay legal fees and costs for two defendants after filing a patent infringement suit that was "exceptionally meritless," a federal judge in Newark has ruled.
1 minute read
By Miriam Rozen | April 12, 2017
Here's a political riddle: What does Republican U.S. Sen. Lindsey Graham of South Carolina have in common with Democratic-leaning plaintiff lawyers, including Lisa Blue, Mikal Watts, Bob Hilliard and Wayne Fisher?
1 minute read
By Tom McParland | April 11, 2017
Bristol-Myers Squibb Co. and Pfizer Inc. on Monday filed a slew of patent infringement suits in Delaware to protect their patents for the successful drug Eliquis and halt the development of generic versions of the profitable blood thinner.
1 minute read
By Max Mitchell | April 10, 2017
A multidistrict antitrust litigation over the generic drugs Digoxin and Doxycycline has been significantly expanded to include numerous additional class action cases, all stemming from a wide-ranging federal probe that last year led two pharmaceutical executives to plead guilty to price-fixing charges.
1 minute read
By Max Mitchell | April 10, 2017
Defendant drug companies in the Xarelto mass tort want to know how the plaintiffs are funding their lawsuits.
1 minute read
By Andrew Denney | April 7, 2017
A federal prosecutor in the securities fraud case against pharmaceutical executive Martin Shkreli and his ex-counsel Evan Greebel accused the defendants on Friday of strategically “ramping up” the animosity between them in an effort to sever their cases.
1 minute read
Presented by BigVoodoo
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Consulting Magazine identifies consultants that have the biggest impact on their clients, firms and the profession.
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
Health Law Associate CT Shipman is seeking an associate to join our national longstanding health law practice. Candidates must have t...
Shipman & Goodwin LLP is seeking two associates to expand our national commercial real estate lending practice. Candidates should have ...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS